Listen Score
LS 25
Global Rank
TOP 10%

BU PODCAST HAKKINDA 🔗

Güncelleme sıklığı:
weekly
Ortalama ses uzunluğu:
24 minutes
Konuk röportajları
ingilizce
Amerika Birleşik Devletleri
361 bölüm
14 Eylül 2018beri
episodic

AUDIENCE OF THIS PODCAST 🔗

~88.42% of listeners are from United States.
🇺🇸
US
88.42%
🇨🇦
CA
6.01%
🇵🇰
PK
2.31%
🇬🇧
GB
1.85%
🇩🇪
DE
0.46%
🇵🇭
PH
0.46%
🇨🇭
CH
0.46%
Others
0.03%
* Data source: directly measured on Listen Notes. gerçek zamanlı

SON ÇIKAN BÖLÜM 🔗

*This episode of the pharmaphorum podcast is brought to you in association with Klick Health* By 2030, 1.2 billion women worldwide will be menopausal or post-menopausal - many at the peak of their working lives. Yet, menopause remains largely absent from health system planning, despite growing evi…

SON BÖLÜMLERİ ARA

pharmaphorum Podcast için geçmiş bölümleri ara.

ÖNCEKİ BÖLÜMLER

Even the most promising innovation still depends on strong governance, resilient operations, and confidence in sensitive data. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Robbie Tyrie, founder and managing director of Torridon Cyber, for a conversation on cybersecurity whe…
Industry is using AI to surface hidden patterns and accelerate decision-making in high-pressure launch environments. In a new pharmaphorum podcast, host Nicole Raleigh speaks with Jason Smith, CTO of AI and analytics at Within3, for a conversation on data-fuelled agile launches and smarter decisio…
Bioconvergence is a multidisciplinary research and development approach that merges technologies from biology, engineering, and computation, providing solutions in medicine, food, agriculture, manufacturing, climate, and more. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sh…
Artificial intelligence is dramatically transforming the landscape for every part of pharma. One area where AI is both essential to implement and important to get right is pharmacovigilance, the group concerned with monitoring and maintaining patient safety.   In today's pharmaphorum podcast, spo…
Earlier this year, the FDA released draft guidance endorsing Bayesian methods and simulation-based evidence in clinical trials in a significant shift in how regulators think about predictive medicine.  In a new pharmaphorum podcast, Dr Irina Babina, CEO of oncology R&D platform Concr, discusse…
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health* Europe continues to offer major life sciences advantages: deep scientific talent, strong clinical expertise, mature research infrastructure, and significant manufacturing capability. Indeed, biotech compa…
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health* When it comes to digital innovation and AI, consideration of using and implementing such responsibly and ethically ever more becomes forefront. But how can pharma lead the way in ethical AI and trust-driv…
Public demand for prevention is surging, with 33.6 million people now using the NHS App, yet, NHS leaders say the digital infrastructure required to deliver prevention at scale isn’t in place. In a new episode of the podcast, pharmaphorum spoke with James Davis, a healthcare expert at PA Consultin…
For a variety of reasons, early stage clinical trials have been moving out of the United States more and more over the past few years, as companies pursue savings and lighter regulatory burden in places like China and Australia. The industry has long urged the US government to take some action to m…
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan pharmaphorum'e aittir.